Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects

INTRODUCTION: Ultra rapid lispro (URLi) is a novel insulin lispro formulation that was developed to more closely match physiological insulin secretion. The aims of this study were to demonstrate the bioequivalence (BE) of a concentrated formulation (U200) of URLi to the U100 formulation of URLi afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Linnebjerg, Helle, LaBell, Elizabeth Smith, Dellva, Mary Anne, Coutant, David E., Leohr, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376802/
https://www.ncbi.nlm.nih.gov/pubmed/32535742
http://dx.doi.org/10.1007/s13300-020-00848-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376802/
https://www.ncbi.nlm.nih.gov/pubmed/32535742
http://dx.doi.org/10.1007/s13300-020-00848-4

Ejemplares similares